Pharmaceuticals, Biotechnology and Life Sciences
Moderna said that the first participants in each age cohort have been dosed in the Company’s Phase 2 study of its mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2).
DOD supercomputers virtually screen millions of drug compounds with SwRI’s Rhodium software SAN ANTONIO–(BUSINESS WIRE)–Using Department of Defense supercomputers, Southwest…
NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for…
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery” report has been added to…
Collaboration will test pre-clinical efficacy and safety of vaccine pipeline including COVID-19 and other coronaviruses PHILADELPHIA & FAIRFAX, Va.–(BUSINESS WIRE)–Chimeron…
– Genentech is also close to completing enrollment of a global randomized, double-blind, placebo-controlled Phase III clinical trial of Actemra…
PhaseBio receives clearance of IND application from U.S. FDA under Coronavirus Treatment Acceleration Program (CTAP)
White Paper on Planning a Drug Launch Amid COVID-19 Released to Summit Attendees, Now Available WALTHAM, Mass.–(BUSINESS WIRE)–#TGaSSummit—Trinity Life Sciences,…
ImmunityBio’s COVID-19 vaccine candidate was selected for Operation Warp Speed, a national program to accelerate COVID-19 vaccine development. Candidate is…
SOLON, Ohio–(BUSINESS WIRE)–As treatment for coronavirus (COVID-19) becomes a global priority, researchers in Brazil are conducting a clinical trial using…